# Editorial: Residual cardiovascular risk in diabetes: current state and future perspectives

**Authors:** Joaquim Oliveira, Thiago Qunaglia, Andrei C. Sposito

PMC · DOI: 10.3389/fcdhc.2026.1774240 · Frontiers in Clinical Diabetes and Healthcare · 2026-02-18

## Full-text entities

- **Genes:** TREM1 (triggering receptor expressed on myeloid cells 1) [NCBI Gene 54210] {aka CD354, TREM-1}
- **Diseases:** heart failure (MESH:D006333), type 2 diabetes (MESH:D003924), liver steatosis (MESH:D005234), proteinuria (MESH:D011507), diabetic kidney disease (MESH:D003928), hyperglycemia (MESH:D006943), thrombotic (MESH:D013927), inflammatory (MESH:D007249), dyslipidemia (MESH:D050171), deaths (MESH:D003643), hypertension (MESH:D006973), endothelial dysfunction (MESH:D014652), Diabetes (MESH:D003920), cardiovascular death (MESH:D002318), kidney failure (MESH:D051437), insulin resistance (MESH:D007333), chronic kidney disease (MESH:D051436), weight loss (MESH:D015431), cardiac arrest (MESH:D006323)
- **Chemicals:** PUFA (MESH:D008055), cholesterol (MESH:D002784), glucose (MESH:D005947), linoleic acid (MESH:D019787), Glycated (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956512/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956512/full.md

---
Source: https://tomesphere.com/paper/PMC12956512